Literature DB >> 29997958

Three-field versus two-field lymph node dissection for thoracic esophageal squamous cell carcinoma: a propensity score-matched comparison.

Longlong Shao1,2, Ting Ye1,2, Longfei Ma1,2, Dong Lin1,2, Hong Hu1,2, Yihua Sun1,2, Yawei Zhang1,2, Jiaqing Xiang1,2, Haiquan Chen1,2.   

Abstract

BACKGROUND: For the surgery of esophageal cancer, cervical, mediastinal, and abdominal lymph node dissection (three-field lymph node dissection, 3FLND) is still controversial in most countries. This study aims to provide additional evidence of this procedure comparing with mediastinal-abdominal lymph node dissection (two-field lymph node dissection, 2FLND) from a high volume center in China, and also attempts to identify routes to reduce postoperative complications associated with 3FLND.
METHODS: From January 2009 to December 2013, 348 consecutive patients received esophagectomy with 3FLND and 1,406 patients received Ivor-Lewis with 2FLND in Fudan University Shanghai Cancer Center. After propensity-score matching, 282 pairs of cases without neoadjuvant treatment were selected. Postoperative outcomes and survival of the two groups were analyzed.
RESULTS: Operative morbidity and mortality rates were 34.8% and 0.4% for 3FLND group; and 25.5% and 0.7% for 2FLND group. Compared with the 2FLND group, the 3FLND group reported more cases of anastomotic leakage (14.9% vs. 4.3%, P<0.001). Multivariate analysis showed that an independent factor of anastomotic leakage was the anastomotic location [HR =0.096 (0.037-0.247), P<0.001] rather than the extent of lymph node dissection. The intrathoracic anastomosis subgroup of 3FLND showed a similar leakage rate as the 2FLND group (4.2% vs. 4.3%). At a median follow-up of 42 months, no significant difference was observed in overall survival between the groups (P=0.529). A subgroup of patients with N1 status who underwent 3FLND showed a better survival trend than those who underwent 2FLND (P=0.093). No significant difference was observed in overall survival between the intrathoracic anastomosis subgroup and cervical anastomosis subgroup (P=0.334).
CONCLUSIONS: Intrathoracic anastomosis may reduce the incidence of anastomotic leakage in esophagectomy with 3FLND, with no compromise on overall survival. Compared with the 2FLND, patients with N1 status might benefit more from the 3FLND technique.

Entities:  

Keywords:  Esophageal squamous cell carcinoma (ESCC); three-field lymph node dissection (3FLND); two-field lymph node dissection (2FLND)

Year:  2018        PMID: 29997958      PMCID: PMC6006065          DOI: 10.21037/jtd.2018.05.69

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  12 in total

1.  Lymph node metastasis in thoracic esophageal carcinoma.

Authors:  H Kato; Y Tachimori; H Watanabe; T Iizuka; S Terui; M Itabashi; T Hirota
Journal:  J Surg Oncol       Date:  1991-10       Impact factor: 3.454

Review 2.  Three-field or two-field resection for thoracic esophageal cancer: a meta-analysis.

Authors:  Ting Ye; Yihua Sun; Yiliang Zhang; Yang Zhang; Haiquan Chen
Journal:  Ann Thorac Surg       Date:  2013-09-20       Impact factor: 4.330

3.  Thoracic recurrent laryngeal lymph node metastases predict cervical node metastases and benefit from three-field dissection in selected patients with thoracic esophageal squamous cell carcinoma.

Authors:  Hecheng Li; Su Yang; Yawei Zhang; Jiaqing Xiang; Haiquan Chen
Journal:  J Surg Oncol       Date:  2011-11-21       Impact factor: 3.454

4.  The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer.

Authors:  Harushi Udagawa; Masaki Ueno; Hisashi Shinohara; Shusuke Haruta; Sachiko Kaida; Masatoshi Nakagawa; Masahiko Tsurumaru
Journal:  J Surg Oncol       Date:  2012-04-13       Impact factor: 3.454

5.  Pattern of lymph node metastases in patients with squamous cell carcinoma of the thoracic esophagus who underwent three-field lymphadenectomy.

Authors:  Hecheng Li; Yawei Zhang; Hui Cai; Jiaqing Xiang
Journal:  Eur Surg Res       Date:  2006-11-10       Impact factor: 1.745

Review 6.  Three-field vs two-field lymph node dissection for esophageal cancer: a meta-analysis.

Authors:  Guo-Wei Ma; Dong-Rong Situ; Qi-Long Ma; Hao Long; Lan-Jun Zhang; Peng Lin; Tie-Hua Rong
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

7.  Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy.

Authors:  R C Karl; R Schreiber; D Boulware; S Baker; D Coppola
Journal:  Ann Surg       Date:  2000-05       Impact factor: 12.969

8.  Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.

Authors:  T Lerut; P Nafteux; J Moons; W Coosemans; G Decker; P De Leyn; D Van Raemdonck; N Ectors
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

9.  Radical lymph node dissection for cancer of the thoracic esophagus.

Authors:  H Akiyama; M Tsurumaru; H Udagawa; Y Kajiyama
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

10.  Factors Affecting Hospital Mortality in Patients with Esophagogastric Anastomotic Leak: A Retrospective Study.

Authors:  Bin Li; Jiaqing Xiang; Yawei Zhang; Hong Hu; Yihua Sun; Haiquan Chen
Journal:  World J Surg       Date:  2016-05       Impact factor: 3.352

View more
  7 in total

1.  A nomogram prediction model for recurrent laryngeal nerve lymph node metastasis in thoracic oesophageal squamous cell carcinoma.

Authors:  Yu Liu; Zhi-Qiang Zou; Juan Xiao; Mei Zhang; Lei Yuan; Xiao-Gang Zhao
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

Review 2.  Past, present, and future of three-field lymphadenectomy for thoracic esophageal cancer.

Authors:  Harushi Udagawa
Journal:  Ann Gastroenterol Surg       Date:  2020-05-14

3.  Survival risk prediction model for patients with pT1-3 N0M0 esophageal squamous cell carcinoma after R0 esophagectomy with two-field lymphadenectomy for therapeutic purposes.

Authors:  Zhan Qi; Yuanping Hu; Rong Qiu; Juan Li; Yuekao Li; Ming He; Yuxiang Wang
Journal:  J Cardiothorac Surg       Date:  2021-05-01       Impact factor: 1.522

4.  Safety and efficacy of minimally invasive McKeown esophagectomy in 1023 consecutive esophageal cancer patients: a single-center experience.

Authors:  Xiao-Dong Zheng; Shi-Cong Li; Chao Lu; Wei-Ming Zhang; Jian-Bin Hou; Ke-Feng Shi; Peng Zhang
Journal:  J Cardiothorac Surg       Date:  2022-03-15       Impact factor: 1.637

5.  Development and validation of a nomogram for prediction of cervical lymph node metastasis in middle and lower thoracic esophageal squamous cell carcinoma.

Authors:  Zhaoyang Yan; Xinjian Xu; Juntao Lu; Yang You; Jinsheng Xu; Tongxin Xu
Journal:  BMC Gastroenterol       Date:  2022-04-03       Impact factor: 3.067

6.  Optimal Range of Lymphadenectomy in Pathological Stage T1 and T2 Esophageal Squamous Cell Carcinoma.

Authors:  Hansheng Wu; Weitao Zhuang; Shujie Huang; Xueting Guan; Yuju Zheng; Zefeng Xie; Gang Chen; Jiming Tang; Haiyu Zhou; Liang Xie; Xiaosong Ben; Zihao Zhou; Zijun Li; Rixin Chen; Guibin Qiao
Journal:  Front Oncol       Date:  2021-05-25       Impact factor: 6.244

7.  High programmed death-ligand 1 expression is a poor prognostic indicator for esophageal squamous cell carcinoma and is correlated with two-field lymph node metastasis.

Authors:  Mingqiang Liang; Fengqiang Yu; Weidong Wu; Hao Chen; Bin Zheng; Wei Zheng; Yong Zhu; Chun Chen
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.